Relay Therapeutics Inc. Common Stock vs Roku Inc. Class A Common Stock — how do they compare? Relay Therapeutics Inc. Common Stock trades at $17.62 (market cap $3.82B), while Roku Inc. Class A Common Stock trades at $153.61 (market cap $22.84B). The key difference: Roku Inc. Class A Common Stock is far larger — about 6× Relay Therapeutics Inc. Common Stock's market cap, and Roku Inc. Class A Common Stock is trading nearer its 52-week high, Relay Therapeutics Inc. Common Stock nearer its low. Which is the better fit depends on your goals — on Pluang, investors hold Relay Therapeutics Inc. Common Stock for 0 Days and Roku Inc. Class A Common Stock for 0 Days on average.
| RLAY | ROKU | |
|---|---|---|
Market Cap | $3.82B | $22.84B |
Volume | 4,332,079 | 1,030,322 |
Sector | Health | Media |
52-Week High | $20.75 | $159.76 |
52-Week Low | $6.03 | $82.93 |
Typical Hold Time | 0 Days | 0 Days |
Enterprise Value | $2.93B | $20.76B |
Trailing returns across standard periods
What Pluang investors did over the last 30 days
Relay Therapeutics develops precision medicines for oncology and genetic diseases. Its drug discovery platform studies how protein motion affects drug targets to guide small-molecule medicine design.
Read more on RLAY →Roku operates a streaming platform that combines its operating system, streaming devices, TV partnerships, and advertising services. It connects viewers with streaming content and services.
Read more on ROKU →